The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant chemoradiation versus surgery first for resectable pancreatic head adenocarcinoma: An economic and outcome analysis.
Daniel Erik Abbott
No relevant relationships to disclose
Ching-Wei David Tzeng
No relevant relationships to disclose
Ryan P. Merkow
No relevant relationships to disclose
Scott B. Cantor
No relevant relationships to disclose
Matthew H.G. Katz
No relevant relationships to disclose
David J. Bentrem
No relevant relationships to disclose
Karl Y. Bilimoria
No relevant relationships to disclose
Christopher H. Crane
No relevant relationships to disclose
Gauri R. Varadhachary
No relevant relationships to disclose
Jason B. Fleming
No relevant relationships to disclose